VR Logo

Fredun Pharmaceuticals Ltd.

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1987

Chairman: Daulat N Medhora

Managing Director: Fredun N Medhora

Group: --

Listing: BSE: 539730

Headquarters: Mumbai, Maharashtra

Website: www.fredungroup.com

Key Facts

Market cap: R 69.76 Cr

Revenue (TTM): R 120.29 Cr

Earnings (TTM): R 3.25 Cr

Cash: R 1.47 Cr

Total Debt: R 9.69 Cr

Promoters' ownership: 52.04%

Liquidity: Moderate

52 Week range: R 103.00 - 443.95

Face value: R10.00

Shares outstanding: 39,89,634

10 Years Aggregate:

  • CFO: 19.54 Cr
  • EBITDA: 28.94 Cr
  • Net Profit: 9.07 Cr

Stock Performance

Time Period Fredun Pharmaceuticals S&P BSE Healthcare* S&P BSE Small Cap*
1 month-7.901.467.10
3 months11.1213.8624.38
1 Year-54.6829.91-6.53
3 Years--4.43-6.96
5 Years---0.572.46
10 Years--11.153.28
As on 13-Jul-2020 *As on 10-Jul-2020
Year Fredun Pharmaceuticals S&P BSE Small Cap S&P BSE Healthcare